Ethema Health Corp (GRST)

[Bubae]

OTC information document for filing requirements.

https://www.otcmarkets.com/files/OTCPinkGuidelines.docx

Current Reporting of Material Corporate Events

Companies are expected to release quickly to the public any news or information regarding corporate events that may be material to the issuer and its securities (including adverse information). Persons with knowledge of such events would be considered to be in possession of material nonpublic information and may not buy or sell the issuer’s securities until or unless such information is made public. If not included in the issuer’s previous public disclosure documents or if any of the following events occur after the publication of such disclosure documents, the issuer shall publicly disclose such events by disseminating a news release within 4 business days following their occurrence and posting such news release through an Integrated Newswire or OTCIQ.

Material corporate events include:

> Entry into or termination of a material definitive agreement
> Completion of an acquisition or disposition of assets, including but not limited to merger transactions
> Creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of an issuer
> Triggering events that accelerate or increase a direct financial obligation or an obligation under an off-balance sheet arrangement
> Costs associated with exit or disposal activities
> Material impairments
> Sales of equity securities
> Material modification to rights of security holders
> Changes in issuer's certifying accountant
> Non-reliance on previously issued financial statements or a related audit report or completed interim review
> Changes in control of issuer
> Departure of directors or principal officers; election of directors; appointment of principal officers
> Amendments to articles of incorporation or bylaws; change in fiscal year
> Amendments to the issuer's code of ethics, or waiver of a provision of the code of ethics
> Any changes to litigation the issuer may be involved in, or any new litigation surrounding the issuer
> Officer, director, or insider transactions in the issuer’s securities
> Disclosure regarding stock promotion campaigns deemed material by the issuer
> Changes to the company’s shell status